1. 00010 ANTIANGIOGENESIS - A NEW TREATMENT MODALITY FOR OVARIAN CANCER PATIENTS. (1st September 2005) Authors: Schröder, W.; Abadie, S.; Witteveen, P. O.; Campone, M.; Viens, P.; Jalava, T.; Masson, E.; Bilic, S.; Chlistalla, A.; du Bois, A. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 0072: Safety and Pharmacokinetic Aspects of Anti-Angiogenic Therapy with Ptk787/Zk 222584 in Combination with Paclitaxel/Carboplatin in Patients with Ovarian Cancer. (1st October 2006) Authors: Schroeder, W.; Campone, M.; Abadie, S.; Witteveen, P. O.; Viens, P.; Jalava, T.; Palacay-Radona, M.; Bilic, S.; Laurent, D.; Du Bois, A. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 3 Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort. (September 2015) Authors: Martin-babau, J.; Robert, M.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Gourmelon, C.; Brunot, A.; Lefeuvre-plesse, C.; Korenbaum, C.; Petit, T.; Marquis, A.; Bourgeois, H.; Uwer, L.; Som, M.; Desclos, H.; Campone, M.; Campion, L.; Tredan, O.; Patsouris, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN). (September 2015) Authors: Patsouris, A.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Jovenin, N.; Robert, M.; Gourmelon, C.; Korembaum, C.; Petit, T.; Martin-babau, J.; Brunot, A.; Lefeuvre-plesse, C.; Adele, M.; Bourgeois, H.; Som, M.; Uwer, L.; Campone, M.; Campion, L.; Tredan, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer. (September 2015) Authors: Campone, M.; Ferrero, J.M.; Gunzer, K.; Priou, F.; Dubreuil, P.; Mansfield, C.; Moussy, A.; Hermine, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ACCESS TO EARLY CLINICAL TRIALS IN OLDER PATIENTS IN FRANCE: AN ANALYSIS OF THE EGALICAN 2 STUDY. (November 2019) Authors: Baldini, C.; Schultz, E.; Auroy, L.; Italiano, A.; Campone, M.; Joly, F.; Isambert, N.; Moreau, P.; Le Gouill, S.; Le Tourneau, C.; Kiladjian, J.; Delord, J.; Roca, C.Gomez; Vey, N.; Barlési, F.; Lesimple, T.; Penel, N.; Massard, C.; Besle, S. Journal: Journal of geriatric oncology Issue: Volume 10(2019)Supplement 1 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Androgen Receptor Expression in Feline Invasive Mammary Carcinomas Confers a Better Clinical Outcome. Issue 1 (January 2016) Authors: Dagher, E.; Jaillardon, L.; Loussouarn, D.; Campone, M.; Abadie, J.; Nguyen, F. Journal: Journal of comparative pathology Issue: Volume 154:Issue 1(2016) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Basal Cytokeratin Expression in Feline Invasive Mammary Carcinomas. Issue 1 (January 2017) Authors: Nguyen, E.; Hobé, F.; Dagher, E.; Loussouarn, D.; Abadie, J.; Fanuel, D.; Campone, M. Journal: Journal of comparative pathology Issue: Volume 156:Issue 1(2017) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BCL-2 Expression in Feline Invasive Mammary Carcinomas is Associated with Better Survival. Issue 1 (January 2017) Authors: Dagher, E.; Loussouarn, D.; Abadie, J.; Campone, M.; Fanuel, D.; Nguyen, F. Journal: Journal of comparative pathology Issue: Volume 156:Issue 1(2017) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. BCL2 Expression in Canine Mammary Carcinomas Confers a Survival Advantage. Issue 1 (January 2016) Authors: Nguyen, F.; Thai, A.; Loussouarn, D.; Campone, M.; Abadie, J. Journal: Journal of comparative pathology Issue: Volume 154:Issue 1(2016) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗